Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01333514 · ClinicalTrials.gov registry record · Phase 4
Carbohydrate Consumption as a Factor in Aspart Dosing
A Phase 4 study, sponsored by Rush University Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 14
- Enrollment target
NCT01333514 is a Phase 4 study that was terminated before completion, run by Rush University Medical Center. The registered enrollment target is 14 participants.
The verdict
NCT01333514, a Phase 4 study, was terminated before completion, sponsored by Rush University Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 14 participants
- Enrollment target
Study Summary
Good sugar control in postoperative hospitalized patient has been shown to improve wound healing and infection rates. However, sugar control is difficult to achieve and suboptimal use of insulin is thought to be a contributory factor. Though it is known that generally the consumption of carbohydrates alone raises the blood sugar, the usual practice of dosing meal-time insulin is based on the fraction of the total meal-tray eaten which includes proteins, fats and carbohydrates. This leads to an overestimation of insulin required for a patient who consumes a portion of mainly proteins and fats on their trays or an underestimation for those eating mainly the carbohydrates on their tray. Low sugars or high blood sugars can follow respectively. Hypothesis: The purpose of this study is to see if dosing meal-time insulin based on grams of carbohydrates consumed will result in better sugar control compared to the usual practice of dosing meal-time insulin based on percent of total meal consumed in hospitalized patients.
Interventions
- DRUG aspart
- DRUG aspart- Insulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2011-04 |
| Est. Completion | 2012-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01333514
The ClinicalTrials.gov registry entry for NCT01333514 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which aspart is the first listed.
NCT01333514 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01333514 about?
NCT01333514 is a clinical study titled "Carbohydrate Consumption as a Factor in Aspart Dosing". Good sugar control in postoperative hospitalized patient has been shown to improve wound healing and infection rates. However, sugar control is difficult to achieve and suboptimal use of insulin is thought to be a contributory factor. Though it is known that generally the consumption of carbohydrate...
What is the current status of trial NCT01333514?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 14 participants. The study started on 2011-04. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01333514?
The interventions under investigation include: aspart (DRUG), aspart- Insulin (DRUG).
Who is sponsoring clinical trial NCT01333514?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.